CONMED logo
CONMED
CNMD | NYSE
Chart Builder DCF Calculator
$49.35
-$1.24 (-2.45%)
At close: Nov 16, 2026, 4:00 PM ET
$49.35
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

CONMED Company Profile

Company profile explained

Company Profile

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.

Key Executives

Name Position
Patrick J. Beyer President, Chief Executive Officer & Director
Richard Glaze Chief Information Officer
Brent Lalomia Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations & IT
Curt R. Hartman Special Advisor
Hollie Foust Executive Vice President, General Counsel and Corporate Secretary
John E. Gallagher Executive VP, CFO and Principal Financial & Accounting Officer
John Ferrell Executive Vice President of Human Resources
Josep Lluis Llorens Executive VP Global Supply Chain Management & Operations
Keith Seaton Vice President of Compliance
Peter K. Shagory Executive Vice President of Strategy & Corporate Development
Todd W. Garner Advisor

Latest SEC Filings

Date Type Title
Oct 28, 2026 10-Q Quarterly Report
Oct 28, 2026 8-K Current Report
Sep 10, 2026 4 Filing
Jul 29, 2026 10-Q Quarterly Report
Jul 29, 2026 8-K Current Report
Jul 17, 2026 4 Filing
Jul 17, 2026 3 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 3 Filing
View All SEC Filings ➞
CONMED
CONMED logo
Country United States
IPO Date Jul 23, 1987
Industry Medical - Devices
Sector Healthcare
Employees 3,900
CEO Patrick J. Beyer

Contact Details

11311 Concept Boulevard Largo, Florida 33773 United States

Stock Details

Ticker Symbol CNMD
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000816956
CUSIP Number 207410101
ISIN Number US2074101013
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.